Shionogi is offering $100 million upfront for San Diego-based Qpex and its three clinical-stage antibiotic programmes, with another $40 million on the table if they meet development and ...

Review Shionogi & Co Ltd ADR (SGIOY:PINX) stock and the current sustainability and ESG risk rating to help with your investing decisions.

David Ehrlich is the Reviews Editor and Head Film Critic at IndieWire. Based in Brooklyn, where he lives with his wife, their two young children, and a cr ...

Shionogi has expanded its partnership with its Alzheimer’s drug development partner Tetra Therapeutics, giving an option for a buyout of the US biotech ahead of a key trial milestone.

Glynn Custred, a professor emeritus in the Department of Anthropology at California State University East Bay, is the author of A History of Anthropology as a Holistic Science. Elizabeth Weiss ...

Review which funds and institutions currently hold Shionogi & Co Ltd ADR (SGIOY:PINX) stock for ownership information.

David Caltabiano is a general assignment reporter for Arizona’s Family. His career began between the trees in Eugene, Oregon, then down south in San Antonio, Texas.

View today's Shionogi & Co., Ltd. stock price and latest 4507 news and analysis. Create real-time notifications to follow any changes in the live stock price.

A high-level overview of Shionogi & Co., Ltd. (SGIOF) stock. View (SGIOF) real-time stock price, chart, news, analysis, analyst reviews and more. Skip to content ...

Glynn is a general assignment and breaking news reporter for The Washington Post. He previously worked for the Houston Chronicle, where he covered business, education, government and sports.